Correlation Between PharmaEngine and Ruentex Development

Can any of the company-specific risk be diversified away by investing in both PharmaEngine and Ruentex Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PharmaEngine and Ruentex Development into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PharmaEngine and Ruentex Development Co, you can compare the effects of market volatilities on PharmaEngine and Ruentex Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PharmaEngine with a short position of Ruentex Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of PharmaEngine and Ruentex Development.

Diversification Opportunities for PharmaEngine and Ruentex Development

-0.22

Correlation Coefficient

PharmaEngine  Ruentex Development

Very good diversification

The 3 months correlation between PharmaEngine and Ruentex is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding PharmaEngine and Ruentex Development Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ruentex Development and PharmaEngine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PharmaEngine are associated (or correlated) with Ruentex Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ruentex Development has no effect on the direction of PharmaEngine i.e., PharmaEngine and Ruentex Development go up and down completely randomly.

Pair Corralation between PharmaEngine and Ruentex Development

Assuming the 90 days trading horizon PharmaEngine is expected to under-perform the Ruentex Development. In addition to that, PharmaEngine is 1.09 times more volatile than Ruentex Development Co. It trades about -0.01 of its total potential returns per unit of risk. Ruentex Development Co is currently generating about 0.05 per unit of volatility. If you would invest  3,580  in Ruentex Development Co on September 15, 2024 and sell it today you would earn a total of  930.00  from holding Ruentex Development Co or generate 25.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

PharmaEngine  vs.  Ruentex Development Co

PharmaEngine

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in PharmaEngine are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, PharmaEngine may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Ruentex Development

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ruentex Development Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Ruentex Development is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with PharmaEngine and Ruentex Development

The main advantage of trading using opposite PharmaEngine and Ruentex Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PharmaEngine position performs unexpectedly, Ruentex Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ruentex Development will offset losses from the drop in Ruentex Development's long position.

The idea behind PharmaEngine and Ruentex Development Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.